ZIVO Bioscience, Inc. (ZIVO)

USD 19.25

(-3.7%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 27.65 Thousand - - 20 Thousand - -
Cost of Revenue 16.04 Thousand - - - - -
Gross Profit 11.61 Thousand - - 20 Thousand - -
Operating Expenses 7.27 Million 8.73 Million 9.05 Million 8.57 Million 8.35 Million 6.13 Million
Selling, General and Administrative Expenses 5.89 Million 6.49 Million 6.93 Million 4.82 Million 6.04 Million 3.31 Million
Research and Development Expenses 1.37 Million 2.24 Million 2.11 Million 3.75 Million 2.3 Million 2.81 Million
Other Expenses - - - - - -
Cost and Expenses 7.29 Million 8.73 Million 9.05 Million 8.57 Million 8.35 Million 6.13 Million
Operating Income -7.26 Million -8.73 Million -9.05 Million -8.55 Million -8.35 Million -6.13 Million
Interest Expense 514.17 Thousand 13.31 Thousand 233.28 Thousand 550.05 Thousand 3.15 Million 8.09 Million
Income Tax Expense - -4.00 233.28 Thousand 550.05 Thousand 3.15 Million 407.48 Thousand
Earnings before Tax -7.77 Million -8.74 Million -9.16 Million -9.1 Million -11.51 Million -14.63 Million
Net Income -7.77 Million -8.74 Million -9.39 Million -9.65 Million -14.66 Million -14.63 Million
Earnings Per Share Basic -4.60 -5.58 -7.40 -11.41 -25.47 -44.84
Earnings Per Share Diluted -4.60 -5.57 -7.39 -11.41 -25.47 -44.84
Weighted Average Shares Outstanding 1.69 Million 1.56 Million 1.26 Million 846.21 Thousand 575.82 Thousand 326.41 Thousand
Weighted Average Shares Outstanding (Diluted) 1.69 Million 1.56 Million 1.27 Million 846.21 Thousand 575.82 Thousand 326.41 Thousand
Gross Margin 0.42 - - 1.00 - -
EBIT Margin -262.68 - - -427.78 - -
Profit Margin -281.27 - - -482.79 - -
EBITDA -7.26 Million -8.73 Million -9.05 Million -550.05 Thousand -8.35 Million -6.13 Million
Earnings Before Tax Margin -262.68 - - -427.78 - -

Income Statement Charts